Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name INT230-6
Trade Name
Synonyms INT 230-6
Drug Descriptions

INT230-6 is a therapy comprised of cisplatin and vinblastine plus a cell penetration excipient, which leads to improved uptake of the drug into cancer cells, potentially resulting in tumor regression as well as indirect antitumor effects (Cancer Res 2015;75(15 Suppl):Abstract nr 4295, PMID: 31646070).

CAS Registry Number NA
NCIT ID C136428


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
INT230-6 INT230-6 0 2
INT230-6 + Pembrolizumab INT230-6 Pembrolizumab 0 0
INT230-6 + unspecified PD-1 antibody INT230-6 unspecified PD-1 antibody 0 1

Additional content available in CKB BOOST